Purvalanol

DB02733ExperimentalSmall molecule

Purvalanol: Overview.

Mechanism: Pharmacologically active on Cyclin-dependent kinase 2
Curator reviewed
Formula / weight: C₂₀H₂₅ClN₆O₃ · 432.904 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyZKDXRFMOHZVXSG-HNNXBMFYSA-NSMILES[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C

Targets

What you can answer from here — as of September 13, 2026

9Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

11+ReferencesStructured and connected to the statements they support

Which drugs share a target with Purvalanol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.